About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Methoxyflurane
- Procedure number
- PSUSA/00010484/202205
- Regulatory outcome
- Variation
Documents
Methoxyflurane : List of nationally authorised medicinal products - PSUSA/00010484/202205
English (EN) (149.32 KB - PDF)
Methoxyflurane : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00010484/202205
English (EN) (51.13 KB - PDF)
български (BG) (92.42 KB - PDF)
español (ES) (87.07 KB - PDF)
čeština (CS) (93.73 KB - PDF)
dansk (DA) (26.57 KB - PDF)
Deutsch (DE) (56.46 KB - PDF)
eesti keel (ET) (86.91 KB - PDF)
ελληνικά (EL) (91.93 KB - PDF)
français (FR) (36.69 KB - PDF)
hrvatski (HR) (97.21 KB - PDF)
íslenska (IS) (27.26 KB - PDF)
Gaeilge (GA) (25.12 KB - PDF)
italiano (IT) (27.09 KB - PDF)
latviešu valoda (LV) (178.79 KB - PDF)
lietuvių kalba (LT) (140.1 KB - PDF)
magyar (HU) (94.88 KB - PDF)
Malti (MT) (136.41 KB - PDF)
Nederlands (NL) (28.4 KB - PDF)
norsk (NO) (87.4 KB - PDF)
polski (PL) (94.78 KB - PDF)
português (PT) (29.59 KB - PDF)
română (RO) (94.75 KB - PDF)
slovenčina (SK) (98.5 KB - PDF)
slovenščina (SL) (106.36 KB - PDF)
Suomi (FI) (24.95 KB - PDF)
svenska (SV) (22.13 KB - PDF)